Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

432 studies match

clinicaltrialsPublishedShowing 101–150 of 432 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05218499	Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma	completed	Phase 2 / Phase 3	400	Boehringer IngelheimINDUSTRY	22	Mar 2, 2026	clinicaltrials
NCT04059484	Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer(AMEERA-3)	terminated	Phase 2	367	SanofiINDUSTRY	23	Feb 24, 2026